HRT Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.83M | Sell |
17,887
-37,286
| -68% | -$12.2M | 0.03% | 373 |
|
|
2025
Q1 | $14.9M | Buy |
55,173
+5,273
| +11% | +$1.42M | 0.09% | 133 |
|
|
2024
Q4 | $11.7M | Buy |
+49,900
| New | +$11.7M | 0.06% | 158 |
|
|
2024
Q2 | – | Sell |
-41,927
| Closed | -$6.27M | – | 1980 |
|
|
2024
Q1 | $6.27M | Buy |
+41,927
| New | +$6.27M | 0.04% | 208 |
|
|
2023
Q4 | – | Sell |
-2,090
| Closed | -$370K | – | 2098 |
|
|
2023
Q3 | $370K | Buy |
+2,090
| New | +$370K | ﹤0.01% | 1394 |
|
|
2022
Q2 | – | Sell |
-1,938
| Closed | -$316K | – | 2788 |
|
|
2022
Q1 | $316K | Buy |
+1,938
| New | +$316K | ﹤0.01% | 1979 |
|
|
2021
Q4 | – | Sell |
-30,777
| Closed | -$5.81M | – | 2820 |
|
|
2021
Q3 | $5.81M | Buy |
30,777
+24,261
| +372% | +$4.58M | 0.04% | 257 |
|
|
2021
Q2 | $1.1M | Buy |
6,516
+1,292
| +25% | +$219K | 0.01% | 915 |
|
|
2021
Q1 | $737K | Buy |
5,224
+3,389
| +185% | +$478K | 0.01% | 1333 |
|
|
2020
Q4 | $238K | Sell |
1,835
-20,589
| -92% | -$2.67M | ﹤0.01% | 1350 |
|
|
2020
Q3 | $3.26M | Buy |
+22,424
| New | +$3.26M | 0.09% | 127 |
|
|
2019
Q2 | – | Sell |
-7,576
| Closed | -$707K | – | 714 |
|
|
2019
Q1 | $707K | Buy |
+7,576
| New | +$707K | 0.11% | 117 |
|